Learn more about the Registry
Alternatively, call the registry team toll-free at 1-877-390-2723 (hours of operation 8.30am - 5.00pm EST Monday-Friday)
The MyRose Pregnancy Registry
Are you pregnant and diagnosed with uterine fibroids or endometriosis and/or have you taken MYFEMBREE® for the treatment of heavy menstrual bleeding due to uterine fibroids or moderate to severe pain related to endometriosis in premenopausal women?
Uterine fibroids and endometriosis can be debilitating conditions. Help future pregnant women, doctors, and researchers understand the safety of medications that may provide some relief.
I am a PatientAre you a healthcare provider who treats pregnant women with uterine fibroids or endometriosis?
Help us learn more about the safety of using MYFEMBREE® for the treatment of heavy menstrual bleeding due to uterine fibroids or moderate to severe pain related to endometriosis in premenopausal women.
I am a Healthcare ProviderAbout the MyRose Pregnancy Registry
A pregnancy registry is a study that collects health information from women who take prescription medicines when they are pregnant. Information also is collected on the infant. This information is compared with women who have not taken medicine or have taken other medicines during pregnancy.
The goal of the MyRose Pregnancy Registry is to help healthcare providers, patients, and researchers better understand the safety of MYFEMBREE® (relugolix, estradiol, and norethindrone acetate)*. Pregnant women in the United States with uterine fibroids or endometriosis may be eligible to participate. The registry collects health information on pregnant women and their babies up to 1 year of age from enrolled pregnant women themselves and the healthcare providers involved in their care or the care of their babies.
*For this pregnancy registry website, MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) may be referred to as relugolix CT (i.e., relugolix containing therapy).
Would you like to participate?
